As of 14 Oct 2026, Arthrosi has raised $153M across 1 verified round on record; latest: $153 million Series E led by Prime Eight Capital, announced 8 Oct 2025.
They develop therapies for gout and chronic kidney disease, primarily targeting gout patients.
arthrosi.comSan Diego, CABiotech
1 source
| Round | Amount | Announced | Lead | Buzz |
|---|---|---|---|---|
| Series E [ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $153M | 2025-10-08 | Prime Eight Capital | No recent discussion |
1 source [ VERIFIED · CORRECTED ] read against 1 source
| ||||